Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-19-002042

Options or other derivatives

  • Director acquired 4,073 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ferrante Karen Jean Director 2019-01-02 Grant or award · Stock Option (Right to Buy) +4,073 $2.70 $10,997 4,073 D
Loading xslF345X03/doc4.xml…